Discovery BMMCs provide post-thaw blast (CD45lo) and plasma cell (CD138+CD38+) counts via flow cytometry. Additionally, blast percentages are taken from the diagnostic Bone Marrow report obtained from the patient’s electronic medical record.
NEW White Paper - Companion Diagnostic Development: An Overview
Primary Human Mast Cells are Now Available
Discovery's Contribution to AR Microscopy Study Featured in Nature
Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis
NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes
NEW White Paper - Companion Diagnostic Development: An Overview
Primary Human Mast Cells are Now Available
Discovery's Contribution to AR Microscopy Study Featured in Nature
Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis
NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes